Oxford Asset Management’s AtriCure ATRC Stock Holding History

Oxford Asset Management’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-49,162	Closed	-$1.6M	–	307
2019 Q4	$1.6M	Sell	49,162 -27,725	-36%	-$789K	0.04%	560
2019 Q3	$1.92M	Sell	76,887 -45,456	-37%	-$1.3M	0.05%	573
2019 Q2	$3.65M	Buy	122,343 +55,100	+82%	+$1.61M	0.08%	373
2019 Q1	$1.8M	Sell	67,243 -23,657	-26%	-$719K	0.04%	631
2018 Q4	$2.78M	Buy	90,900 +16,628	+22%	+$518K	0.07%	322
2018 Q3	$2.58M	Buy	74,272 +32,129	+76%	+$1.02M	0.05%	523
2018 Q2	$1.14M	Buy	42,143 +21,819	+107%	+$513K	0.02%	963
2018 Q1	$417K	Sell	20,324 -8,243	-29%	-$149K	0.01%	1313
2017 Q4	$528K	Buy	28,567 +8,202	+40%	+$162K	0.01%	1160
2017 Q3	$457K	Buy	+20,365	New	+$460K	0.01%	1226
2014 Q3	–	Sell	-90,801	Closed	-$1.68M	–	670
2014 Q2	$1.68M	Sell	90,801 -48,889	-35%	-$814K	0.05%	416
2014 Q1	$2.63M	Buy	+139,690	New	+$2.86M	0.08%	314
2013 Q3	–	Sell	-17,617	Closed	-$167K	–	791
2013 Q2	$167K	Buy	+17,617	New	+$153K	﹤0.01%	807

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Oxford Asset Management's ATRC Position: Q1 2020 in Review

Oxford Asset Management sold out of AtriCure (ATRC) in Q1 2020, closing a stake of 49,162 shares — an estimated $1.6M sold.

Oxford Asset Management first reported a position in ATRC in Q2 2013 and held it in 13 quarters. The position peaked at $3.65M in Q2 2019. 155 funds tracked by Wall St. Rank hold ATRC as of Q1 2020.

Oxford Asset Management reported no remaining AtriCure position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 49,162 AtriCure shares in Q1 2020, an estimated $1.6M.
Oxford Asset Management first reported a position in AtriCure in Q2 2013 and held it in 13 quarters.
Oxford Asset Management's AtriCure position peaked at $3.65M in Q2 2019.
155 funds tracked by Wall St. Rank held AtriCure as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.